India sees 18,522 COVID-19 cases and 418 deaths in last 24 hours as Centre issues Unlock 2.0 guidelines
New Delhi | Jagran News Desk: India recorded 18,522 COVID-19 cases on Monday to take its overvall caseload past 5.6-lakh mark. Meanwhile, 418 fatalities in the last 24 hours took country's death toll to 16,893.
India has been over 15,000 cases every day for the past one week now. Amid the alarming spike in cases and deaths, the Centre on Monday issued guidelines for the month-long 'Unlock 2' beginning July 1.
Under Unlock 2.0, more domestic flights and passenger trains will be allowed in a calibrated manner, while educational institutions, Metro Rail services, cinema halls and gyms will remain shut.
Maharashtra, Delhi and Haryana are among the states making a big push for use of convalescent plasma therapy for treatment of critical coronavirus patients as new COVID-19 cases in the country rose by over 15,000 for the sixth consecutive day.
|Name of State / UT||Active Cases*||Cured/Discharged/Migrated*||Deaths**||Total Confirmed cases*|
|Andaman and Nicobar Islands||44||46||0||90|
|Dadra and Nagar Haveli and Daman and Diu||126||77||0||203|
|Jammu and Kashmir||2557||4585||95||7237|
|Cases being reassigned to states||7004||7004|
Hours before the guidelines were issued by the MHA on Monday night, Maharashtra and Tamil Nadu extended the lockdown till July 31 without any more relaxations, joining West Bengal and Manipur. Nagaland also extended the lockdown with existing curbs but like in Manipur it will be in force only till July 15.
Maharashtra Chief Minister Uddhav Thackeray launched a convalescent plasma therapy-cum-trial project with a state medical education department official calling it the "largest" initiative of its kind in the world.
In the national capital, Delhi Chief Minister Arvind Kejriwal announced setting up of a 'plasma bank' while Haryana Health Minister Anil Vij said the state will soon start convalescent plasma therapy in all its medical colleges.
Plasma therapy involves taking antibodies from the blood of a person who has recovered from COVID-19 and transfusing those into a coronavirus patient to help kickstart the immune system to fight the infection.
According to the ICMR's 'Clinical Management Protocols for COVID-19', convalescent plasma therapy, also called passive antibody therapy, may be considered for patients with moderate illness with no improvement in condition despite the use of steroids. The recipient is to be closely monitored for several hours after transfusion for any adverse events and its use should be avoided in patients with immunoglobulin A deficiency or immunoglobulin allergy.
Posted By: abhinav gupta